Istari Oncology
About:
Istari Oncology is a biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma.
Website: http://www.istarioncology.com/
Description:
Istari Oncology is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The Company was founded in 2016 by Darell Bigner, MD, and Matthias Gromeier, MD to continue research and clinical development of technology discovered at Duke University.
$48.5M
$1M to $10M
Durham, North Carolina, United States
2014-01-01
info(AT)istarioncology.com
Dani P. Bolognesi, Matthias Gromeier
11-50
2021-04-22
Private
© 2025 bioDAO.ai